Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | VIO-01 |
| Synonyms | |
| Therapy Description |
VIO-01 is a DNA decoy-cholesterol conjugate, which binds to DNA damage repair proteins and potentially inhibits DNA damage repair and induces an antitumor immune response (Cancer Res (2024) 84 (6_Supplement): 6013). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| VIO-01 | VIO01|VIO 01|OX425|OX 425|OX-425 | VIO-01 is a DNA decoy-cholesterol conjugate, which binds to DNA damage repair proteins and potentially inhibits DNA damage repair and induces an antitumor immune response (Cancer Res (2024) 84 (6_Supplement): 6013). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06257758 | Phase Ib/II | VIO-01 | A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors | Terminated | USA | 0 |